{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:25:29Z","timestamp":1761708329647},"reference-count":114,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8,20]]},"DOI":"10.1097\/qad.0b013e3282ff6265","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T21:47:33Z","timestamp":1236289653000},"page":"1527-1537","source":"Crossref","is-referenced-by-count":16,"title":["New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users"],"prefix":"10.1097","volume":"22","author":[{"given":"Mirjam","family":"Kretzschmar","sequence":"first","affiliation":[]},{"given":"Lucas","family":"Wiessing","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R2-1-20210130","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(00)04562-1","article-title":"Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis","volume":"357","author":"Kral","year":"2001","journal-title":"Lancet"},{"key":"R4-1-20210130","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1097\/01.aids.0000242824.59377.53","article-title":"Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study","volume":"20","author":"Lindenburg","year":"2006","journal-title":"AIDS"},{"key":"R5-1-20210130","doi-asserted-by":"crossref","first-page":"iii7","DOI":"10.1093\/jurban\/jtg078","article-title":"The role of sexual transmission of HIV infection among injection and noninjection drug users","volume":"80","author":"Strathdee","year":"2003","journal-title":"J Urban Health"},{"key":"R6-1-20210130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002030-200001070-00009","article-title":"Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia","volume":"14","author":"Beyrer","year":"2000","journal-title":"AIDS"},{"key":"R7-1-20210130","first-page":"49","article-title":"Relationship of national highway with injecting drug abuse and HIV in rural Manipur, India","volume":"41","author":"Sarkar","year":"1997","journal-title":"Indian J Public Health"},{"issue":"Suppl 3","key":"R8-1-20210130","first-page":"iii10","article-title":"Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution","volume":"82","author":"Aceijas","year":"2006","journal-title":"Sex Transm Infect"},{"key":"R9-1-20210130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0955-3959(02)00224-4","article-title":"Modelling emerging HIV epidemics: the role of injecting drug use and sexual transmission in the Russian federation","volume":"14","author":"Grassly","year":"2003","journal-title":"Int J Drugs Policy"},{"key":"R10-1-20210130","first-page":"E061123","article-title":"Ongoing HIV and viral hepatitis infections in IDU across the EU, 2001-2005.","volume":"11","author":"Wiessing","year":"2006","journal-title":"Eurosurveillance"},{"key":"R11-1-20210130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(03)12831-0","article-title":"HIV in central and eastern Europe","volume":"361","author":"Hamers","year":"2003","journal-title":"Lancet"},{"key":"R12-1-20210130","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200209060-00002","article-title":"Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia","volume":"16","author":"Rhodes","year":"2002","journal-title":"AIDS"},{"key":"R13-1-20210130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00042560-199910010-00011","article-title":"Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China","volume":"22","author":"Yu","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R14-1-20210130","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/00002030-199410000-00020","article-title":"The epidemiology of HIV infection among injecting drug users and other risk populations in Thailand","volume":"8","author":"Nelson","year":"1994","journal-title":"AIDS"},{"key":"R15-1-20210130","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cld.2006.08.003","article-title":"The changing epidemiology and natural history of hepatitis C virus infection","volume":"10","author":"Bialek","year":"2006","journal-title":"Clin Liver Dis"},{"key":"R16-1-20210130","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","article-title":"Epidemiology of hepatitis C virus infection","volume":"13","author":"Alter","year":"2007","journal-title":"World J Gastroenterol"},{"key":"R18-1-20210130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/QAI.0b013e318141f965","article-title":"Gender differences in sex risk behaviors among Ukraine injection drug users","volume":"46","author":"Booth","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-1-20210130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/09595230701373925","article-title":"Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme","volume":"26","author":"Islam","year":"2007","journal-title":"Drug Alcohol Rev"},{"key":"R20-1-20210130","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s10096-005-1376-9","article-title":"Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours","volume":"24","author":"Mathei","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R21-1-20210130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jmv.20486","article-title":"Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands","volume":"77","author":"van de Laar","year":"2005","journal-title":"J Med Virol"},{"key":"R23-1-20210130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2165\/00003495-200262030-00009","article-title":"Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C","volume":"62","author":"Scott","year":"2002","journal-title":"Drugs"},{"key":"R24-1-20210130","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","article-title":"Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)","volume":"352","author":"Poynard","year":"1998","journal-title":"Lancet"},{"key":"R25-1-20210130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.aids.0000202651.41397.db","article-title":"Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: effectiveness goes on","volume":"20","author":"P\u00e9rez-Hoyos","year":"2006","journal-title":"AIDS"},{"key":"R26-1-20210130","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.drugpo.2007.01.013","article-title":"Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach","volume":"18","author":"Birkhead","year":"2007","journal-title":"Int J Drugs Policy"},{"key":"R28-1-20210130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugpo.2007.02.010","article-title":"Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002\u20132004","volume":"18","author":"Donoghoe","year":"2007","journal-title":"Int J Drugs Policy"},{"key":"R32-1-20210130","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1172\/JCI21540","article-title":"Acute HIV revisited: new opportunities for treatment and prevention","volume":"113","author":"Pilcher","year":"2004","journal-title":"J Clin Invest"},{"key":"R33-1-20210130","first-page":"163","article-title":"HIV prevalence among intravenous drug users: model-based estimates from New Haven's legal needle exchange","volume":"5","author":"Kaplan","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R34-1-20210130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0002-9343(93)90263-O","article-title":"Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut","volume":"95","author":"Heimer","year":"1993","journal-title":"Am J Med"},{"key":"R35-1-20210130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0169-4758(88)90034-8","article-title":"Density-dependence in parasite transmission dynamics","volume":"4","author":"Dietz","year":"1988","journal-title":"Parasitol Today"},{"key":"R36-1-20210130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/imammb\/14.1.11","article-title":"Mathematical modelling of the spread of HIV\/AIDS amongst injecting drug users","volume":"14","author":"Greenhalgh","year":"1997","journal-title":"IMA J Math Appl Med Biol"},{"key":"R37-1-20210130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/imammb\/17.2.95","article-title":"Three-stage AIDS incubation period: a best case scenario using addict-needle interaction assumptions","volume":"17","author":"Greenhalgh","year":"2000","journal-title":"IMA J Math Appl Med Biol"},{"key":"R38-1-20210130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s002850200140","article-title":"The general mixing of addicts and needles in a variable-infectivity needle-sharing environment","volume":"44","author":"Greenhalgh","year":"2002","journal-title":"J Math Biol"},{"key":"R39-1-20210130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1098\/rstb.1991.0006","article-title":"Drugs, sex and HIV: a mathematical model for New York City","volume":"331","author":"Blower","year":"1991","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R40-1-20210130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1360-0443.1992.tb01938.x","article-title":"Epidemiology, HIV and drugs: mathematical models and data","volume":"87","author":"Blower","year":"1992","journal-title":"Br J Addict"},{"key":"R41-1-20210130","first-page":"1086","article-title":"Monte Carlo simulation of HIV infection in an intravenous drug user community","volume":"3","author":"Peterson","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R42-1-20210130","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00002030-199807000-00017","article-title":"Modelling the spread of HIV in social networks of injecting drug users","volume":"12","author":"Kretzschmar","year":"1998","journal-title":"AIDS"},{"key":"R43-1-20210130","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/aje\/152.10.913","article-title":"Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation","volume":"152","author":"Friedman","year":"2000","journal-title":"Am J Epidemiol"},{"key":"R44-1-20210130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.drugpo.2006.02.008","article-title":"Modelling the spread of hepatitis C virus infection among injecting drug users in Glasgow: Implications for prevention","volume":"17","author":"Hutchinson","year":"2006","journal-title":"Int J Drugs Policy"},{"key":"R45-1-20210130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0955-3959(02)00209-8","article-title":"Potential impact of HIV among IDUs on heterosexual transmission in Asian settings: the Asian epidemic model","volume":"14","author":"Saidel","year":"2003","journal-title":"Int J Drugs Policy"},{"key":"R46-1-20210130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0955-3959(03)00027-6","article-title":"Can HIV epidemics among IDUs \u2018trigger\u2019 a generalised epidemic?","volume":"14","author":"Wiessing","year":"2003","journal-title":"Int J Drugs Policy"},{"issue":"Suppl 1","key":"R47-1-20210130","doi-asserted-by":"crossref","first-page":"i19","DOI":"10.1136\/sti.2004.010165","article-title":"The Asian Epidemic Model: a process model for exploring HIV policy and programme alternatives in Asia","volume":"80","author":"Brown","year":"2004","journal-title":"Sex Transm Infect"},{"key":"R48-1-20210130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(04)16593-8","article-title":"HIV\/AIDS in Asia","volume":"364","author":"Ruxrungtham","year":"2004","journal-title":"Lancet"},{"key":"R49-1-20210130","article-title":"Modelling the transmission of hepatitis C in injecting drug users","author":"Kretzschmar","year":"2004"},{"key":"R50-1-20210130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/01.qai.0000219788.73539.47","article-title":"Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users","volume":"42","author":"Vickerman","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R51-1-20210130","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/ije\/dyl276","article-title":"Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study","volume":"36","author":"Vickerman","year":"2007","journal-title":"Int J Epidemiol"},{"key":"R52-1-20210130","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1046\/j.1440-1746.1999.02014.x","article-title":"Modelling the hepatitis C virus epidemic in Australia. Hepatitis C Virus Projections Working Group","volume":"14","author":"Law","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"R53-1-20210130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ije\/dyg101","article-title":"Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia","volume":"32","author":"Law","year":"2003","journal-title":"Int J Epidemiol"},{"key":"R54-1-20210130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.20836","article-title":"Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland","volume":"42","author":"Hutchinson","year":"2005","journal-title":"Hepatology"},{"key":"R55-1-20210130","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/ije\/20.4.997","article-title":"A new method of estimating prevalence of injecting drug use in an urban population: results from a Scottish city","volume":"20","author":"Frischer","year":"1991","journal-title":"Int J Epidemiol"},{"key":"R56-1-20210130","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1046\/j.1360-0443.2001.9610146510.x","article-title":"A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain","volume":"96","author":"Frischer","year":"2001","journal-title":"Addiction"},{"key":"R57-1-20210130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/1606635031000135622","article-title":"Estimating the number of drug injectors from needle exchange data","volume":"11","author":"Hay","year":"2003","journal-title":"Addiction Res Theory"},{"key":"R58-1-20210130","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1097\/00002030-199812000-00017","article-title":"The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis","volume":"12","author":"Hendriks","year":"1998","journal-title":"AIDS"},{"key":"R59-1-20210130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/01621459.1988.10478599","article-title":"A method for obtaining short-term projections and lower bounds on the size of the AIDS epidemic","volume":"83","author":"Brookmeyer","year":"1988","journal-title":"J Am Statist Association"},{"key":"R60-1-20210130","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/00002030-199011000-00010","article-title":"Surveillance of AIDS in the European Community: recent trends and predictions to 1991","volume":"4","author":"Downs","year":"1990","journal-title":"AIDS"},{"key":"R61-1-20210130","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1097\/00002030-200009290-00015","article-title":"Back-calculation by birth cohort, incorporating age- specific disease progression, pre-AIDS mortality and change in European AIDS case definition. European Union concerted action on multinational AIDS scenarios","volume":"14","author":"Downs","year":"2000","journal-title":"AIDS"},{"key":"R62-1-20210130","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/aje\/153.7.632","article-title":"Estimating the relative incidence of heroin use: application of a method for adjusting observed reports of first visits to specialized drug treatment agencies","volume":"153","author":"Hickman","year":"2001","journal-title":"Am J Epidemiol"},{"key":"R63-1-20210130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1360-0443.2001.9634337.x","article-title":"Back-projection estimates of the number of dependent heroin users in Australia","volume":"96","author":"Law","year":"2001","journal-title":"Addiction"},{"key":"R64-1-20210130","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(06)68804-1","article-title":"Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis","volume":"367","author":"Nordt","year":"2006","journal-title":"Lancet"},{"key":"R65-1-20210130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2105\/AJPH.64.12_Suppl.16","article-title":"Recent spread of heroin use in the United States","volume":"64","author":"Hunt","year":"1974","journal-title":"Am J Publ Health"},{"key":"R66-1-20210130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2334-6-93","article-title":"Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales","volume":"6","author":"Sutton","year":"2006","journal-title":"BMC Infect Dis"},{"key":"R67-1-20210130","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2893.2006.00725.x","article-title":"Evidence for a substantial role of sharing of injecting paraphernalia other than syringes\/needles to the spread of hepatitis C among injecting drug users","volume":"13","author":"Mathei","year":"2006","journal-title":"J Viral Hepat"},{"key":"R68-1-20210130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0272989X0102100502","article-title":"Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users","volume":"21","author":"Pollack","year":"2001","journal-title":"Med Decis Making"},{"key":"R69-1-20210130","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/01.olq.0000221335.80508.fa","article-title":"The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine","volume":"33","author":"Vickerman","year":"2006","journal-title":"Sex Transm Dis"},{"key":"R70-1-20210130","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/j.1360-0443.2004.00899.x","article-title":"The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus","volume":"99","author":"Kumaranayake","year":"2004","journal-title":"Addiction"},{"issue":"Suppl 2","key":"R71-1-20210130","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/01.aids.0000172874.90133.7a","article-title":"Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries","volume":"19","author":"McDougal","year":"2005","journal-title":"AIDS"},{"key":"R72-1-20210130","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa042291","article-title":"Detection of acute infections during HIV testing in North Carolina","volume":"352","author":"Pilcher","year":"2005","journal-title":"N Engl J Med"},{"key":"R73-1-20210130","first-page":"510","article-title":"Application of laboratory methods for estimation of HIV-1 incidence","volume":"121","author":"Parekh","year":"2005","journal-title":"Indian J Med Res"},{"key":"R74-1-20210130","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1128\/JCM.43.12.6197-6199.2005","article-title":"Comparison of the avidity index method and the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections","volume":"43","author":"Martro","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R75-1-20210130","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1086\/506625","article-title":"Treatment of acute HIV-1 infection: is it coming of age?","volume":"194","author":"Kinloch-de Loes","year":"2006","journal-title":"J Infect Dis"},{"key":"R76-1-20210130","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/512088","article-title":"High rates of forward transmission events after acute\/early HIV-1 infection","volume":"195","author":"Brenner","year":"2007","journal-title":"J Infect Dis"},{"key":"R77-1-20210130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0277-9536(94)90302-6","article-title":"Social networks and infectious disease: the Colorado Springs Study","volume":"38","author":"Klovdahl","year":"1994","journal-title":"Soc Sci Med"},{"issue":"Suppl 1","key":"R78-1-20210130","doi-asserted-by":"crossref","first-page":"i159","DOI":"10.1136\/sti.78.suppl_1.i159","article-title":"Risk network structure in the early epidemic phase of HIV transmission in Colorado Springs","volume":"78","author":"Potterat","year":"2002","journal-title":"Sex Transm Infect"},{"key":"R79-1-20210130","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1360-0443.2006.01431.x","article-title":"The dynamics of injection drug users' personal networks and HIV risk behaviors","volume":"101","author":"Costenbader","year":"2006","journal-title":"Addiction"},{"key":"R80-1-20210130","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0277-9536(95)00193-X","article-title":"Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens","volume":"42","author":"Grund","year":"1996","journal-title":"Soc Sci Med"},{"key":"R81-1-20210130","first-page":"140","article-title":"The network approach and interventions to prevent HIV among injection drug users","volume":"113","author":"Neaigus","year":"1998","journal-title":"Public Health Rep"},{"key":"R82-1-20210130","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.drugalcdep.2007.02.013","article-title":"Distributive syringe sharing among young adult injection drug users in five U.S. cities","volume":"91","author":"Golub","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"R83-1-20210130","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/378355","article-title":"Assessing resistance costs of antiretroviral therapies via measures of future drug options","volume":"188","author":"Jiang","year":"2003","journal-title":"J Infect Dis"},{"key":"R84-1-20210130","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jama.297.7.724","article-title":"Molecular diagnostics of hepatitis C virus infection: a systematic review","volume":"297","author":"Scott","year":"2007","journal-title":"JAMA"},{"key":"R86-1-20210130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00038-007-5123-0","article-title":"2nd-generation HIV surveillance and injecting drug use: uncovering the epidemiological ice-berg","volume":"52","author":"Reintjes","year":"2007","journal-title":"Int J Public Health"},{"key":"R87-1-20210130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/510858","article-title":"Hepatitis C virus coinfection and superinfection","volume":"195","author":"Blackard","year":"2007","journal-title":"J Infect Dis"},{"key":"R88-1-20210130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2893.2006.00812.x","article-title":"High incidence of hepatitis C virus reinfection within a cohort of injecting drug users","volume":"14","author":"Micallef","year":"2007","journal-title":"J Viral Hepat"},{"key":"R89-1-20210130","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0140-6736(02)08435-0","article-title":"Protection against persistence of hepatitis C","volume":"359","author":"Mehta","year":"2002","journal-title":"Lancet"},{"key":"R90-1-20210130","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drugalcdep.2007.09.011","article-title":"A prospective study to examine persistent HCV reinfection in injecting drug users who have previously cleared the virus","volume":"93","author":"Currie","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"R91-1-20210130","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtbi.2004.02.015","article-title":"Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives","volume":"228","author":"Gomes","year":"2004","journal-title":"J Theor Biol"},{"key":"R92-1-20210130","first-page":"156","article-title":"Hepatitis C virus and human immunodeficiency virus coinfection: where do we stand?","volume":"63","author":"Arends","year":"2005","journal-title":"Neth J Med"},{"key":"R93-1-20210130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11908-007-0051-y","article-title":"Pathogenesis of HIV-HCV coinfection","volume":"9","author":"Kim","year":"2007","journal-title":"Curr Infect Dis Rep"},{"key":"R94-1-20210130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/004912418101000205","article-title":"Snowball sampling: problems and techniques of chain referral sampling","volume":"10","author":"Biernacki","year":"1981","journal-title":"Sociological Methods Res"},{"key":"R95-1-20210130","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00005053-198709000-00009","article-title":"Temporal and social contexts of heroin-using populations. An illustration of the snowball sampling technique","volume":"175","author":"Kaplan","year":"1987","journal-title":"J Nerv Ment Dis"},{"key":"R96-1-20210130","first-page":"31","article-title":"Methodological and design issues: techniques for assessing the representatives of snowball samples","volume":"98","author":"van Meter","year":"1990","journal-title":"NIDA Res Monogr"},{"key":"R97-1-20210130","first-page":"79","article-title":"Sampling Issues in Drug Epidemiology","author":"Taylor","year":"2005"},{"key":"R98-1-20210130","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1007\/s11524-006-9108-8","article-title":"Implementation and analysis of respondent driven sampling: lessons learned from the field","volume":"83","author":"Abdul-Quader","year":"2006","journal-title":"J Urban Health"},{"key":"R99-1-20210130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11524-006-9052-7","article-title":"Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study","volume":"83","author":"Abdul-Quader","year":"2006","journal-title":"J Urban Health"},{"key":"R100-1-20210130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00178324","article-title":"On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations","volume":"28","author":"Diekmann","year":"1990","journal-title":"J Math Biol"},{"key":"R101-1-20210130","doi-asserted-by":"crossref","first-page":"i39","DOI":"10.1007\/s11524-006-9101-2","article-title":"Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia","volume":"83","author":"Platt","year":"2006","journal-title":"J Urban Health"},{"key":"R102-1-20210130","doi-asserted-by":"crossref","first-page":"i6","DOI":"10.1007\/s11524-006-9098-6","article-title":"Exploring barriers to \u2018respondent driven sampling\u2019 in sex worker and drug-injecting sex worker populations in Eastern Europe","volume":"83","author":"Simic","year":"2006","journal-title":"J Urban Health"},{"key":"R103-1-20210130","doi-asserted-by":"crossref","first-page":"i83","DOI":"10.1007\/s11524-006-9104-z","article-title":"Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: recruitment dynamics and impact on estimates of HIV and syphilis prevalence","volume":"83","author":"Frost","year":"2006","journal-title":"J Urban Health"},{"key":"R105-1-20210130","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.aids.0000304690.24390.c2","article-title":"Overview of the HIV\/AIDS epidemic, scientific research and government responses in China","volume":"21","author":"Wang","year":"2007","journal-title":"AIDS"},{"key":"R106-1-20210130","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1097\/01.aids.0000304704.71917.64","article-title":"Effectiveness of first eight methadone maintenance treatment clinics in China","volume":"21","author":"Pang","year":"2007","journal-title":"AIDS"},{"issue":"Suppl 1","key":"R107-1-20210130","first-page":"107","article-title":"Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City","volume":"113","author":"Hartel","year":"1998","journal-title":"Public Health Rep"},{"key":"R108-1-20210130","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.drugpo.2005.02.004","article-title":"Effectiveness of sterile needle and syringe programmes","volume":"16S","author":"Wodak","year":"2005","journal-title":"Int J Drugs Policy"},{"key":"R109-1-20210130","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1360-0443.2007.01818.x","article-title":"Rate of detoxification service use and its impact among a cohort of supervised injecting facility users","volume":"102","author":"Wood","year":"2007","journal-title":"Addiction"},{"key":"R111-1-20210130","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1360-0443.2006.01519.x","article-title":"Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users","volume":"101","author":"Amundsen","year":"2006","journal-title":"Addiction"},{"key":"R112-1-20210130","article-title":"Annual, voluntary examination, testing and counselling of IDUs. Abstract presented at the 2005 EMCDDA expert meeting on drug related infectious diseases","author":"Blystad","year":"2005"},{"key":"R113-1-20210130","article-title":"The impact and cost-effectiveness of methadone maintenance treatment in preventing HIV and hepatitis C","author":"Pollack","year":"2004"},{"key":"R114-1-20210130","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users","volume":"102","author":"van den Berg","year":"2007","journal-title":"Addiction"},{"key":"R115-1-20210130","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/ije\/dyg102","article-title":"The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users","volume":"32","author":"Murray","year":"2003","journal-title":"Int J Epidemiol"},{"key":"R116-1-20210130","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.socscimed.2006.09.019","article-title":"Expansion of HIV\/AIDS in China: lessons from Yunnan Province","volume":"64","author":"Xiao","year":"2007","journal-title":"Soc Sci Med"},{"key":"R117-1-20210130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1473-3099(06)70685-5","article-title":"HIV in prison in low-income and middle-income countries","volume":"7","author":"Dolan","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"R119-1-20210130","doi-asserted-by":"crossref","first-page":"i57","DOI":"10.1136\/sti.2005.016543","article-title":"Behavioural data as an adjunct to HIV surveillance data","volume":"82","author":"Garnett","year":"2006","journal-title":"Sex Transm Infect"},{"key":"R120-1-20210130","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/genetics\/155.3.1429","article-title":"An integrated framework for the inference of viral population history from reconstructed genealogies","volume":"155","author":"Pybus","year":"2000","journal-title":"Genetics"},{"key":"R121-1-20210130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.meegid.2004.08.001","article-title":"The hepatitis C virus epidemic among injecting drug users","volume":"5","author":"Pybus","year":"2005","journal-title":"Infect Genet Evol"},{"key":"R122-1-20210130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2148-7-116","article-title":"Patterns of genetic variation in populations of infectious agents","volume":"7","author":"Gordo","year":"2007","journal-title":"BMC Evol Biol"},{"key":"R123-1-20210130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/505760","article-title":"Coexistence and specialization of pathogen strains on contact networks","volume":"168","author":"Eames","year":"2006","journal-title":"Am Nat"},{"key":"R124-1-20210130","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/35082140","article-title":"The web of human sexual contacts","volume":"411","author":"Liljeros","year":"2001","journal-title":"Nature"},{"key":"R125-1-20210130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.socnet.2006.08.002","article-title":"An introduction to exponential random graph (p*) models for social networks","volume":"29","author":"Robins","year":"2007","journal-title":"Soc Netw"},{"key":"R126-1-20210130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.socnet.2006.08.003","article-title":"Recent developments in exponential random graph (p*) models for social networks","volume":"29","author":"Robins","year":"2007","journal-title":"Soc Netw"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200808200-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T19:16:42Z","timestamp":1633202202000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200808200-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,20]]},"references-count":114,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3282ff6265","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8,20]]}}}